John Vandermosten
LightNews LightNews
vanjohn10.bsky.social
John Vandermosten
@vanjohn10.bsky.social
31 followers 44 following 540 posts
Life Sciences, Analyst, Media Operations, Investor Awareness
Owner of Unboxing Biotech, a channel that features life sciences executives and their companies.
Posts Replies Media Videos
vanjohn10.bsky.social
GeoVax #CEO David Dodd provides his perspective on new approaches to #vaccine distribution in developing and remote regions.
#biotech #biotechnology #science
December 16, 2025 at 5:22 PM
vanjohn10.bsky.social
Trinity Capital’s Rob Lake looks at private capital’s ability to stretch runway to achieve milestones while minimizing dilution
$TRIN
#LifeSciences #BiotechInnovation #BiotechFunding #MedTech #HealthTech #BioTechStartups #BioPharma #DrugDevelopment #ClinicalResearch #Therapeutics #PharmaInnovation
December 16, 2025 at 5:00 PM
vanjohn10.bsky.social
#CEO David Dodd looks at the possible futures for GeoVax and the company’s focus during a surge in M&A activity.
#biotech #biotechnology #science #GeoVax #Gedeptin #CancerTherapy #GeneTherapy #HeadAndNeckCancer #SolidTumor #CancerResearch #Oncology #InnovativeMedicine #Biotech #TargetedTherapy
December 13, 2025 at 7:37 PM
vanjohn10.bsky.social
Trinity Capital’s Rob Lake looks at private capital’s ability to stretch runway to achieve milestones while minimizing dilution
$TRIN
#LifeSciences #BiotechInnovation #BiotechFunding #MedTech #HealthTech #BioTechStartups #BioPharma #DrugDevelopment #ClinicalResearch #Therapeutics #PharmaInnovation
December 13, 2025 at 7:34 PM
vanjohn10.bsky.social
GeoVax' #CEO David A. Dodd looks at the Modified Vaccinia Ankara (MVA) platform & how $GOVX is adapting it to be used in developing and developed regions alike.
#biotech #biotechnology #science #GeoVax #Gedeptin #CancerTherapy #GeneTherapy #HeadAndNeckCancer #SolidTumor #CancerResearch #Oncology
December 12, 2025 at 8:54 PM
vanjohn10.bsky.social
Trinity Capital’s Rob Lake looks at some of the ways his platform recycles capital as investments achieve milestones or are acquired.
$TRIN
#LifeSciences #BiotechInnovation #BiotechFunding #MedTech #HealthTech #BioTechStartups #BioPharma #DrugDevelopment #ClinicalResearch #Therapeutics
December 11, 2025 at 6:45 PM
vanjohn10.bsky.social
Trinity Capital’s Rob Lake offers a solution to young companies that may not realize the benefits of private capital.
$TRIN
#LifeSciences #BiotechInnovation #BiotechFunding #MedTech #HealthTech #BioTechStartups #BioPharma
December 9, 2025 at 10:54 PM
vanjohn10.bsky.social
GeoVax #CEO David Dodd explains why there has been a re-emergence of measles in the United States and other developed regions.
$GOVX
#biotech #biotechnology #science #GeoVax
December 6, 2025 at 7:36 PM
vanjohn10.bsky.social
Trinity Capital’s Rob Lake shares thoughts on some technologies that have potential in the life sciences.
$TRIN
#LifeSciences #BiotechInnovation #BiotechFunding #MedTech #HealthTech #BioTechStartups #BioPharma #DrugDevelopment #ClinicalResearch #Therapeutics #PharmaInnovation
December 6, 2025 at 7:26 PM
vanjohn10.bsky.social
GeoVax #CEO David Dodd emphasizes the importance of a multi-antigen vaccine. He calls for Congress to act in support of domestic biomanufacturing and biodevelopment.
$GOVX
#biotech #biotechnology #science #GeoVax #Gedeptin #GeneTherapy #CancerResearch #Oncology #InnovativeMedicine #Biotech
December 4, 2025 at 10:44 PM
vanjohn10.bsky.social
Trinity Capital’s Rob Lake describes some of the financing options for biotech companies.
$TRIN
#LifeSciences #BiotechInnovation #BiotechFunding #MedTech #HealthTech #BioTechStartups #BioPharma #DrugDevelopment #ClinicalResearch #Therapeutics #PharmaInnovation
December 4, 2025 at 9:33 PM
vanjohn10.bsky.social
We speak with Trinity Capital’s Life Sciences Lead Rob Lake. He explains the components of return for private capital.
$TRIN
#LifeSciences #BiotechInnovation #BiotechFunding #MedTech #HealthTech #BioPharma #DrugDevelopment #ClinicalResearch #Therapeutics
trinitycapital.com/life-sciences/
December 2, 2025 at 5:19 PM
vanjohn10.bsky.social
GeoVax CEO David Dodd compares the US and China's #biotech industries & shares steps to take to maintain our leading position.
$GOVX
#biotech #biotechnology #science #GeoVax #Gedeptin #CancerTherapy #GeneTherapy #HeadAndNeckCancer #SolidTumor #CancerResearch
December 2, 2025 at 2:33 PM
vanjohn10.bsky.social
Rani Therapeutics' #CEO Talat Imran describes the Rani Pill and how it works along with listing some of the leading biologics that are appropriate $RANI partners.
#Biotech #BioPharma #PharmaInnovation #DrugDevelopment #ClinicalTrials #MedTech #HealthTech #LifeSciences #FutureOfMedicine #Therapeutics
November 30, 2025 at 7:13 PM
vanjohn10.bsky.social
Dr. Ann Childress, principal investigator on Cingulate’s CTx-1301 trials, highlights some of the differences in ADHD symptoms between children and adults.
#ADHD #Neuroscience #Biotech #SmallCapBiotech #BiotechInvesting #ClinicalPipeline #DrugDevelopment #NASDAQ
October 27, 2025 at 3:13 PM
vanjohn10.bsky.social
Reviva Pharmaceuticals' #CEO Laxminarayan Bhat, Ph.D. shares examples of positive and negative symptoms in schizophrenia. #FDA
$RVPH
#schizophrenia #biopharma #biotech
October 23, 2025 at 1:43 PM
vanjohn10.bsky.social
Dr Ann Childress, principal investigator on #Cingulate CTx-1301 trials, comments on an article that finds an association between use of ADHD medication and lower suicide risk.
$CING
www.bmj.com/content/390/...
#ADHD #Biotech #DrugDevelopment #ADHDTreatment #NASDAQ
October 22, 2025 at 4:26 PM
vanjohn10.bsky.social
Dr. Ann Childress, principal investigator on Cingulate's CTx-1301 trials, shares a story about ADHD medications that only work for part of the day.
$CING
#Cingulate #ADHD #Neuroscience #Biotech #BiotechStocks #LifeSciences #NASDAQ
October 20, 2025 at 7:08 PM
vanjohn10.bsky.social
Dr. Ann Childress describes how the new #ADHD medication CTx-1301 works in this brief clip.
$CING
#Cingulate #Biotech #ClinicalTrials #LifeSciences #ADHDResearch #BiotechInvesting #PharmaNews #NASDAQ
October 18, 2025 at 4:32 PM
vanjohn10.bsky.social
Chief Commercial Officer Jaime Xinos explains Achieve Life Sciences’ strategy to deploy digital resources for maximum effect.
$ACHV
#SmokingCessation #ClinicalTrials #BiotechInnovation #LifeSciences #PublicHealth #AddictionResearch #TobaccoFreeFuture #HealthEquity #MedicalResearch #Biopharma
October 13, 2025 at 12:49 PM
vanjohn10.bsky.social
Reviva Pharmaceuticals' #CEO Dr Bhat elaborates on brilaroxazine’s sustained efficacy and low discontinuation rate.
#schizophrenia #biopharma #biotech
October 12, 2025 at 11:02 AM
vanjohn10.bsky.social
Achieve Life Sciences’ CEO Rick Stewart identifies varenicline side effects that may have led to discontinuation and compares with cytisinicline.
$ACHV
#SmokingCessation #ClinicalTrials #LifeSciences #AddictionResearch #TobaccoFreeFuture #HealthEquity #MedicalResearch #Biopharma
October 11, 2025 at 2:06 PM
vanjohn10.bsky.social
Lexaria Bioscience CEO Richard Christopher summarizes details from $LEXX human clinical trials evaluating #DehydraTECH & GLP1 agonists along with the technology’s key benefits.
#LexariaBioscience #LexariaDelivery #NextGenDrugDelivery #OralDeliveryTech #OralPeptideDelivery #GLP1Therapy #GLP1Agonist
October 6, 2025 at 8:27 PM
vanjohn10.bsky.social
Founder & CEO Bernard Peperstraete explains how Acuamark Diagnostics uses the qPCR technology & modifies it for better performance in cancer detection.
#methylation #Diagnostics #MedicalDiagnostics #LabTesting #Healthcare #MedicalTesting #DiagnosticServices #LabServices
September 29, 2025 at 8:52 PM
vanjohn10.bsky.social
Founder & CEO Bernard Peperstraete provides the context behind Acuamark Diagnostics' anticipated capital raise, outlines related milestones and plans additional studies to further characterize the cancer diagnostic.
#methylation #Diagnostics #MedicalDiagnostics #LabTesting #Healthcare
September 26, 2025 at 10:30 PM